poster

LATITUDE: Long-Acting Antipsychotic Treatments in Community Telepsychiatry: Knowledge, Attitudes, and Perceived Barriers

Abstract: Background/Objective: The South Carolina Department of Mental Health instituted a Community Telepsychiatry Program (CTP) to increase patient access to mental health practitioner...

01/19/2023

Characteristics of Patients with Major Depressive Disorder and Acute Suicidal Ideation or Behavior Initiated on Esketamine or Traditional Therapies in the United States

Abstract: BACKGROUND: Adults with major depressive disorder with acute suicidal ideation or behavior (SIB; MDSI) initiated on esketamine or traditional therapies were described to underst...

01/19/2023

Aripiprazole plasma concentrations delivered from two 2-month long-acting injectable formulations: an indirect comparison

Abstract: Background: Aripiprazole 2-month ready-to-use 960 mg (2MRTU 960) is a new formulation of aripiprazole monohydrate intended for the treatment of schizophrenia or maintenance mono...

01/19/2023

Long-term safety and Effectiveness of Lurasidone in Adolescents and Young Adults With Schizophrenia: Pooled Post-hoc Analyses of Two 12-month Extension Studies

Abstract: Introduction: The aim of this pooled analysis was to evaluate the long-term safety and effectiveness of lurasidone in the treatment of schizophrenia in adolescents (13-17 years)...

01/19/2023

Efficacy and Safety of Lurasidone in a Younger Population With Bipolar Depression: Pooled Post-hoc Analysis of Two Placebo-controlled Studies

Abstract: Introduction: The aim of this analysis was to evaluate the efficacy and safety of lurasidone in bipolar depression in youth and young adult patients (10-30 years old). Methods:...

01/19/2023

KickStart30: A 30-Day Nursing Wellness Initiative

Abstract: The goal of this study was to explore the efficacy and feasibility of an integrated, prescriptive, and trackable 30-day wellness intervention combining five wellness elements in...

01/19/2023

Positive and Negative Syndrome Scale Five-Factor Analysis Investigating the Efficacy of HP-3070 Transdermal System in Adults With Schizophrenia

Abstract: Background: HP-3070, a once-daily asenapine transdermal system, is FDA-approved for adults with schizophrenia. The Positive and Negative Syndrome Scale (PANSS) score’s five-fact...

01/19/2023

Efficacy of Adjunctive Brexpiprazole in Patients With Major Depressive Disorder and Partial Response to Antidepressant Treatment: a Post Hoc Analysis of Three Randomized Studies

Abstract: Background: Approximately 50% of patients with major depressive disorder (MDD) have unresolved symptoms of depression on antidepressant treatment (ADT), which are associated wit...

01/19/2023

Efficacy of Adjunctive Brexpiprazole in Patients With Unresolved Symptoms of Depression on Antidepressant Treatment Who Are Early in the Disease Course: a Post Hoc Analysis of Four Randomized Studies

Abstract: Background: Approximately 50% of patients with major depressive disorder (MDD) have unresolved symptoms of depression on antidepressant treatment (ADT). For such patients, early...

01/19/2023

TD360: Outcomes of a Tardive Dyskinesia Educational Curriculum – A Focus on Quality of Life, Increased Detection and Novel Treatments

TD360 Background

11/01/2020

Tracks

MDD Insights

Schizophrenia Insights

Major Depressive Disorder

General Psychiatry

ADHD

About

Celebrating 35 years of empowering the highest standard in mental healthcare, Psych Congress serves as a unique, integrated forum to connect members of the entire mental health team—bringing together psychiatrists, nurse practitioners, physician assistants, psychologists, primary care physicians, and other mental health professionals for 4 days of practical education to improve patient care.

December 9 ⁠–⁠ December 11

March 31 ⁠–⁠ April 2

April 21 ⁠–⁠ April 24

May 28 ⁠–⁠ May 31

See Full Calendar

poster

Tracks

About

Specialties

Events

Year Round Education

HMP Global Products